Ceftazidime Injectable (Iv/Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM)
Available Strengths: 1 g, 2 g, 2.5 g, 3 g, 4 g per vial
Reference Brands: Fortaz, Tazicef(US& EU)
Category: Antibiotics
Ceftazidime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against Pseudomonas aeruginosa and other gram-negative bacteria. Benefits include rapid, potent action in severe infections, broad-spectrum activity, and utility in hospital settings for pneumonia, sepsis, and complicated infections.
Product Description:
Ceftazidime injectable is approved in the EU and US for treating severe bacterial infections, including pneumonia, sepsis, and complicated urinary tract infections. In the EU, brands like Fortaz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data and manufacturing compliance, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers and compliance, visit PharmaTradz. We support seamless market access, ensuring adherence to European and American standards for safe, effective antibacterial therapy.
Ceftazidime Injectable (Iv/Im) — third party manufacturing & bulk supply
Ceftazidime Injectable (Iv/Im) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ceftazidime Injectable (Iv/Im) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ceftazidime Injectable (Iv/Im) →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ceftazidime is an antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and bloodstream infections. It is especially effective against Gram-negative bacteria, including Pseudomonas aeruginosa.
Ceftazidime is made from the active pharmaceutical ingredient ceftazidime, which belongs to the third-generation cephalosporin class of antibiotics. It works by interfering with bacterial cell wall synthesis, leading to bacterial cell death.
Common trade names include Fortaz, Ceptaz, and Tazicef.
Ceftazidime is manufactured by multiple pharmaceutical companies worldwide. The original brand Fortaz is marketed by GlaxoSmithKline (GSK) in some regions, while generic versions are produced by various other manufacturers.
The generic name is ceftazidime.
Brand names include Fortaz, Ceptaz, and Tazicef, along with multiple regional generics.
Ceftazidime is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
